InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

- Current share price for IBX : $0.005

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Appendix 3Y x 5 27 Jun 2019 3:42PM $0.017 $0.005 fallen by 70.59%
$4 Ceasing to be a substantial holder 25 Jun 2019 5:35PM $0.017 $0.005 fallen by 70.59%
$4 Appendix 3B 24 Jun 2019 10:38AM $0.017 $0.005 fallen by 70.59%
$4 Release of Securities Subject to Escrow 7 Jun 2019 8:27AM $0.024 $0.005 fallen by 79.17%
$4 Results of Annual General Meeting 31 May 2019 12:37PM $0.025 $0.005 fallen by 80%
$4 Chairman's Address to Shareholders at Annual General Meeting 31 May 2019 10:43AM $0.025 $0.005 fallen by 80%
$4 Imagion Biosystems successfully completes toxicology study 23 May 2019 8:29AM $0.024 $0.005 fallen by 79.17%
$4 Non-Deal Roadshow Presentation 21 May 2019 5:05PM $0.023 $0.005 fallen by 78.26%
$4 Imagion Biosystems receives R&D Advanced Overseas Finding 13 May 2019 1:39PM $0.023 $0.005 fallen by 78.26%
$4 Notice of Annual General Meeting/Proxy Form 2 May 2019 8:27AM $0.030 $0.005 fallen by 83.33%
$4 Appendix 4G and Corporate Governance Statement 30 Apr 2019 11:00AM $0.030 $0.005 fallen by 83.33%
$4 Annual Report to shareholders 30 Apr 2019 11:00AM $0.030 $0.005 fallen by 83.33%
$4 Appendix 4C - quarterly 26 Apr 2019 8:23AM $0.030 $0.005 fallen by 83.33%
$4 IBX receives order related to cancer treatment 11 Apr 2019 8:39AM $0.025 $0.005 fallen by 80%
$4 FY2018 Financial Report 29 Mar 2019 3:25PM $0.025 $0.005 fallen by 80%
$4 IBX receives US patent related to treatment of disease 12 Mar 2019 8:44AM $0.030 $0.005 fallen by 83.33%
$4 FY2018 Appendix 4E and Preliminary Report 28 Feb 2019 3:32PM $0.028 $0.005 fallen by 82.14%
$4 Imagion Biosystems initiates toxicology study 20 Feb 2019 9:35AM $0.029 $0.005 fallen by 82.76%
$4 Appendix 4C - quarterly 31 Jan 2019 10:22AM $0.037 $0.005 fallen by 86.49%
$4 Becoming a substantial holder 30 Jan 2019 5:29PM $0.037 $0.005 fallen by 86.49%
$4 Becoming a substantial holder 30 Jan 2019 5:25PM $0.037 $0.005 fallen by 86.49%
$4 IBX teams with Planet Innovation to develop MagSense 17 Dec 2018 9:22AM $0.036 $0.005 fallen by 86.11%
$4 Cleansing Notice 28 Nov 2018 4:30PM $0.047 $0.005 fallen by 89.36%
$4 Appendix 3B 28 Nov 2018 4:22PM $0.047 $0.005 fallen by 89.36%
$4 Change of Director's Interest Notice 30 Oct 2018 4:13PM $0.043 $0.005 fallen by 88.37%

601 - 625 of 695 results

Page 25 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.